Clinical Study on Floium Ginkgo Extract and Tertram Ethypyrazine Sodium Chloride injection in Treatment of Acute Ischemic Stroke

The First Hospital of China Medical University0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1) aged >= 18 years;
•2) acute ischemic stroke patients with first symptom onset;
•3) symptom onset within 4.5 hours and eligible for criteria for IV-tPA treatment;
•4) baseline NIHSS score range from 7 to 22;
•5) written informed consent has been provided by patients or their legal proxies.

•1) Allergic to the drug components in this study.
•2) Oral or intravenous application of other drugs similar to the mechanism of Floium Ginkgo Extract and Tertram Ethypyrazine Sodium Chloride injection before stroke onset(28 days).
•3) Epilepsy with stroke onset.
•4) Other lesions in the brain, history of mental illness.
•5) History of chronic liver disease, liver and kidney dysfunction, elevated alanine aminotransferase (> 3 times the upper limit of normal), and elevated serum creatinine (> 2 times the upper limit of normal).
•6) Pregnant or lactating women.
•7) Other severe, advanced or terminal illnesses with life expectancy of less than 3 months, or inability to complete study follow-up due to other reasons.
•8) Other circumstances that the researchers consider not appropriate for this study.

发起方